Navigation Links
HackensackUMC is First in New Jersey and New York Metropolitan Area to Perform Groundbreaking Robotic Surgery
Date:3/22/2012

ommitted to remaining at the forefront of innovation and technology, driven to provide our patients the best medical care we are able to deliver. This latest innovation is just a natural progression of the focus of HackensackUMC to be in the vanguard of the healthcare industry," said Dr. Stephen Pereira. "This surgery is only the beginning of many more noteworthy surgical advancements. The approval of the single incision platform for gallbladder surgery will likely lead to the future approval of the system for use in other procedures."

Leading in Robotic Surgery

HackensackUMC has been at the forefront of robotic surgery for over a decade. Robotic surgery began at HackensackUMC in 2000 with two da Vinci™ robots. The medical center went on to become the first institution in the world to own three, then four, and then as many as six da Vinci systems on a single campus. It currently has five: three da Vinci Si HD™ Surgical Systems, the latest robots in the da Vinci surgical product line, and two former versions are used to train physicians, as Hackensack is a designated da Vinci Training Center in the Northeast.

"The surgical care we're able to offer our patients with the da Vinci Si HD™ Surgical System is unmatched," said Ihor Sawczuk, M.D., of Rockleigh, chairman of the Department of Urology and chief of Urologic Oncology at the John Theurer Cancer Center at HackensackUMC. "The da Vinci offers minimally invasive alternatives to complex surgical procedures with tremendous positive clinical results for patients."

For over a decade, surgeons at HackensackUMC have performed more than 4,000 successful robotic surgeries in four specialties: Urology, Obstetrics & Gynecology, Thoracic Surgery and General Surgery. HackensackUMC performs the highest volume of robotic surgeries in New Jersey and is among the world leaders in robotic surgery volume.

"The robotic-assisted single incision surgery demonstrates Hackensa
'/>"/>

SOURCE Hackensack University Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HackensackUMC Adopts SurgiCount Safety-Sponge® System
2. Evergreen Hospital to Perform Regions First Single-Incision Gallbladder Removal
3. Mylan One of First to Launch Generic Version of Boniva®
4. China Botanic Reports First Quarter Fiscal 2012 Results
5. CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
6. United Spinal Creates UsersFirst Mobility Map: First On-line Tool for Wheelchair Consumers
7. U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB)
8. Everist Genomics Develops Worlds First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
9. Data in NEJM shows Novartis drug Signifor® is first therapy to provide rapid, durable benefit for Cushings disease patients in Phase III study
10. Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx
11. MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... & Forecast – Worldwide Analysis ... Pump Market Analysis ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... MOUNTAIN VIEW, Calif., Feb. 28, 2011 VIVUS, ... to the development and commercialization of novel therapeutic products, today ... and year ended December 31, 2010. ... development program, we successfully completed the two-year SEQUEL study, an ...
... The staffs of Chiltern International Limited (Chiltern), a global ... 25 year mark of their successful collaboration in Drug ... have worked together using a validated and regulatory accepted ... assessment of drug phototoxicity. The history of this collaboration ...
Cached Medicine Technology:VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 2VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 3VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 4VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 5VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 6VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 7Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 2Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 3
(Date:7/9/2014)... July 9, 2014 There has been a sharp ... Southwestern Medical Center using MyChart, the online, interactive service ... communicate with their healthcare providers, schedule appointments, and renew ... patients actively using MyChart each year increased ... increased more than 10-fold, according to a study by ...
(Date:7/9/2014)... have been linked to an emerging fungal disease ... Institute for Mathematical and Biological Synthesis (NIMBioS) shows ... , In a series of mathematical models, researchers ... internal organs in frogs, could cause extinction of ... exposed to the virus every few years, a ...
(Date:7/9/2014)... flatulence and have a reputation for being highly toxic, but ... now being being found to offer potential health benefits in ... and dementia. A new compound (AP39), designed and made at ... therapies, by targeting delivery of very small amounts of the ... , Scientists in Exeter have already found that the compound ...
(Date:7/9/2014)... most important organs in the human body. Its job ... this is its synthesis function and that ... is its detoxification function. Lack of exercise and too ... liver. The resulting diseased cells can lead to inflammations, ... According to the German Liver Foundation, over five million ...
(Date:7/9/2014)... labels handed out by pharmacists may be misread ... according to new research by the University of ... Blind)., The study, published recently in the ... prescription medications dispensed by pharmacies do not consistently ... simply following recommended guidelines for font size, use ...
Breaking Medicine News(10 mins):Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... A specific gene is particularly frequently involved in the development ... sequences of genetic material on the X and Y chromosome ... children. These gene regulators determine how frequently a gene is ... mutation of one regulatory sequence of the SHOX gene is ...
... Small babies at risk for osteoporosis decades later, study finds ... born preterm with a very low birth weight have significantly ... full term, a Finnish study has found. , The researchers ... 27, who were born preterm with very low birth weight. ...
... , , FRANKLIN, Mass., Aug. 25 ... on innovative cardiac and vascular medical device-based technologies, today announced ... its RenalGuard System(TM) has been published, in advance of the ... - September 2, 2009 in Barcelona, Spain, on the ESC ...
... , CLEVELAND, Aug. 25 As part of ... Cleveland is proud to have been recognized as part of the ... International Business Awards. The IBA selected Jani-King,s entry as the ... and individuals from 27 countries, including first-time winners from Japan, New ...
... Aug. 25 Moszkito(R), the name in "healthy flip-flops," is ... include closed footwear for Fall 2009. The 4 new styles, ... 16 mm arch support. In black and brown Italian Waxed ... , Based in Scottsdale, Arizona, Moszkito has established ...
... , NEW YORK, Aug. 25 Impelsys ( ... leader in electronic content delivery solutions, today announced that the American ... www.i p u blishcentral.com ), an ... monetize traditional print content through electronic channels. , ...
Cached Medicine News:Health News:Not only the gene itself, its abnormal regulation can also trigger short stature 2Health News:Not only the gene itself, its abnormal regulation can also trigger short stature 3Health News:PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard(R) at ESC 2009 Has Been Published; Strong Preliminary Results Seen 2Health News:PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard(R) at ESC 2009 Has Been Published; Strong Preliminary Results Seen 3Health News:PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard(R) at ESC 2009 Has Been Published; Strong Preliminary Results Seen 4Health News:Jani-King Recognized as Best in Support by the International Business Awards 2Health News:Moszkito(R) Expands its Archy(TM) Footwear Collection to Include Closed-Toed Shoes for Fall 2009 2Health News:American Medical Association Launches e-Book Strategy with iPublishCentral from Impelsys 2Health News:American Medical Association Launches e-Book Strategy with iPublishCentral from Impelsys 3
... Sunglasses collection benefits from innovative research in ... sectors such as the aerospace and automotive ... field and the footwear and textile industry. ... reinvented in the Carrera sunglasses collection to ...
Bottega Venetas new collection expresses a unique style and determined personality: discreet elegance and refined luxury are the themes that inspire the creation of these new models, destined to beco...
The new Stella McCartney sunglasses collection seduces with its sensual appeal and vintage spirit.,Bold patterned finishes, glamourous colour combinations and intricate details make the designers,cre...
The Claiborne brand provides the perfect look for the man who wants to be comfortable and relaxed, yet look appropriate for each occasion....
Medicine Products: